Protalix BioTherapeutics Announces Poster Presentations at t

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and...

Related Keywords

Germany , United States , United Kingdom , Israel , Brazil , Carmiel , Ha Afon , American , Chiesi Farmaceutici , Chuck Padala , Protalix Biotherapeutics Inc , United Kingdom Charitable Organization Manchester , Drug Administration , Prnewswire Protalix Biotherapeutics Inc , Conference Center , Pfizer Inc , Maritim Hotel , Fabry Disease , Registered United Kingdom Charitable Organization , Pegunigalsidase Alfa , Agalsidase Beta , Renal Function , Month Results , Multicenter Extension Study , Adult Patients , Infusion Duration , Agalsidase Alfa , Treat Patients , Treatment Data , Pegunigalsidase Alfa Administered Every ,